Trial
NCT07259564
A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Collaborators
—
Condition
Adult Growth Hormone Deficiency (AGHD)
Intervention
GS3-007a dry suspension
Why stopped
Adjustment of sponsor's product development strategy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-22